Could zapping a different brain region tame epilepsy?
NCT ID NCT04692701
First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 2 times
Summary
This pilot study tests deep brain stimulation (DBS) of the medial pulvinar, a new target in the brain, for people with drug-resistant epilepsy who have not improved with other treatments. Twelve adults aged 18 to 60 will receive the stimulation and track their seizures for 12 months. The goal is to see if this approach can reduce seizure frequency and improve quality of life.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- deep brain stimulation device targeting the medial pulvinar
- What this could lead to
- If successful, this could offer a new treatment option for people with drug-resistant epilepsy who have not responded to other therapies.
- What could go wrong
- This is a very small pilot study with only 12 participants, so results may not apply widely. The approach is still experimental and may not reduce seizures significantly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
12 people
The number who actually took part.
- Started
-
Jan 2021
- Finished
-
Jul 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age: between 18 and 60 years old * Focal or multifocal drug-resistant epilepsy not operable or failure of epilepsy surgery * Vagal nerve stimulation failure (after at least 1 year of treatment or stopped early for worsening seizures) * Either patients with epilepsy whose characteristics suggest that it may respond better to stimulation of the pulvinar than the anterior thalamic nucleus stimulation (i.e. posterior quadrant epilepsy, motor/premotor epilepsy, operculo-insular epilepsy, temporal plus epilepsy, lateral temporal epilepsy) or/and patients with previous anterior thalamic nucleus stimulation failure (after 2 years of treatment or stopped early for worsening seizures) * Number of seizures \> 4 / month during the baseline (3 months) and before the V0 for at least 3 months * Total IQ \> 55 * Give written consent to the study after receiving clear information * Be a beneficiary or affiliated to a health insurance plan * For women of childbearing potential, a pregnancy test must be negative before inclusion. Exclusion Criteria: * Difficulty to read or understand the French language, or inability to understand the information regarding the study. * Generalized epilepsy * Presenting contraindication to MRI, a serious intercurrent pathology, a progressive brain tumor. * Pregnancy or breastfeeding * Present a history of attempted suicide in the 6 months prior to inclusion or a score ≥ 2 in item 10 of the Montgomery and Asberg Depression Scale (MADRS). * Present a surgical or anaesthetic contraindication. * Require long-term anticoagulant or platelet aggregation therapy. * Hereditary bleeding disorders of coagulation * Non obliterated AVM * History of Herpes virus brain infection * Total IQ below 55. * Patients with less than 4 seizures a month * To be hospitalized under duress (HO / HDT) * Major under guardianship or curatorship * Person deprived of liberty by judicial decision * Patient currently participating in another clinical trial or having participated in a clinical trial in the month prior to inclusion
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Epilepsy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Service de Neurologie
Nice, 13385, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can lavender and lullabies help kids with epilepsy sleep better?
- Reading the Brain's signals to predict who benefits from deep brain stimulation
- Can a Comfort-Focused education program improve life with epilepsy?
- Can video games rewire young brains after injury?
- High-Fat Diet's effect on epilepsy: scientists track brain signals
- Epilepsy drug candidate put to the test in healthy volunteers